Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Irritable Bowel Syndrome

  Free Subscription


Articles published in Am J Gastroenterol

Retrieve available abstracts of 80 articles:
HTML format



Single Articles


    December 2022
  1. SPIEGEL B
    Gravity and the Gut: A Hypothesis of Irritable Bowel Syndrome.
    Am J Gastroenterol. 2022;117:1933-1947.
    PubMed     Abstract available


    November 2022
  2. D'SILVA A, Marshall DA, Vallance JK, Nasser Y, et al
    Meditation and Yoga for Irritable Bowel Syndrome: A Randomized Clinical Trial.
    Am J Gastroenterol. 2022 Nov 25. doi: 10.14309/ajg.0000000000002052.
    PubMed     Abstract available


    October 2022
  3. BRENNER DM, Lacy BE, Ford AC, Bartolini W, et al
    Linaclotide Reduced Response Time for Irritable Bowel Syndrome with Constipation Symptoms: Analysis of Four Randomized Controlled Trials.
    Am J Gastroenterol. 2022 Oct 12. pii: 00000434-990000000-00551.
    PubMed     Abstract available


    September 2022
  4. VILLANUEVA-MILLAN MJ, Leite G, Wang J, Morales W, et al
    Methanogens and Hydrogen Sulfide Producing Bacteria Guide Distinct Gut Microbe Profiles and Irritable Bowel Syndrome Subtypes.
    Am J Gastroenterol. 2022 Sep 6. pii: 00000434-990000000-00500.
    PubMed     Abstract available


    August 2022
  5. NORDIN E, Hellstrom PM, Brunius C, Landberg R, et al
    Modest conformity between self-reporting of Bristol stool form and fecal consistency measured by stool water content in irritable bowel syndrome, a FODMAP and gluten trial.
    Am J Gastroenterol. 2022 Aug 12. pii: 00000434-990000000-00449.
    PubMed     Abstract available


    July 2022
  6. VOLLEBREGT PF, Wiklendt L, Burgell RE, Chaichanavichkij P, et al
    Abnormal Perception of Urge to Defecate: An Important Pathophysiological Mechanism in Women With Chronic Constipation.
    Am J Gastroenterol. 2022;117:1125-1136.
    PubMed     Abstract available


    June 2022
  7. HUANG Z, Lin Z, Lin C, Chu H, et al
    Transcutaneous Electrical Acustimulation Improves Irritable Bowel Syndrome with Constipation by Accelerating Colon Transit and Reducing Rectal Sensation via Autonomic Mechanisms.
    Am J Gastroenterol. 2022 Jun 17. pii: 00000434-990000000-00418.
    PubMed     Abstract available


  8. TACK J, Tornblom H, Tan V, Carbone F, et al
    Evidence-Based and Emerging Dietary Approaches to Upper Disorders of Gut-Brain Interaction.
    Am J Gastroenterol. 2022;117:965-972.
    PubMed     Abstract available


    May 2022
  9. VAN DEN HOUTE K, Bercik P, Simren M, Tack J, et al
    Mechanisms underlying food-triggered symptoms in disorders of gut-brain interactions.
    Am J Gastroenterol. 2022 May 4. pii: 00000434-990000000-00357.
    PubMed     Abstract available


  10. DULANEY DT
    Continuing Medical Education Questions: May 2022.
    Am J Gastroenterol. 2022;117:720.
    PubMed     Abstract available


  11. LACY BE, Cangemi DJ
    A Pragmatic Approach to the Evaluation and Treatment of Abdominal Bloating.
    Am J Gastroenterol. 2022;117:701-705.
    PubMed    


    April 2022
  12. ZHANG X, Xiao X, Yang JL
    Shall we reduce endoscopy in patients with irritable bowel syndrome?
    Am J Gastroenterol. 2022 Apr 15. pii: 00000434-990000000-00342.
    PubMed    


  13. SINGH P, Tuck C, Gibson PR, Chey WD, et al
    The Role of Food in the Treatment of Bowel Disorders: Focus on Irritable Bowel Syndrome and Functional Constipation.
    Am J Gastroenterol. 2022 Apr 8. pii: 00000434-990000000-00347.
    PubMed     Abstract available


  14. BRENNER DM, Harris LA, Chang CH, Waldman SA, et al
    Real-World Treatment Strategies to Improve Outcomes in Patients With Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation.
    Am J Gastroenterol. 2022;117.
    PubMed     Abstract available


  15. KASSEBAUM-LADEWSKI A, Poppers DM, Brenner DM
    Effective Communication Strategies and Tools for Improving Treatment Outcomes in Patients With Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation.
    Am J Gastroenterol. 2022;117.
    PubMed     Abstract available


  16. SAYUK GS, Waldman SA, Brenner DM
    Mechanisms of Action of Current Pharmacologic Options for the Treatment of Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation.
    Am J Gastroenterol. 2022;117.
    PubMed     Abstract available


  17. HARRIS LA, Chang CH
    Burden of Constipation: Looking Beyond Bowel Movements.
    Am J Gastroenterol. 2022;117.
    PubMed     Abstract available


  18. BRENNER DM
    Best Practices for the Management of Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation: A Roundtable Discussion and Review.
    Am J Gastroenterol. 2022;117.
    PubMed    


    March 2022
  19. PIMENTEL M, Mathur R, Wang J, Chang C, et al
    A Smartphone Application Using Artificial Intelligence Is Superior to Subject Self-Reporting When Assessing Stool Form.
    Am J Gastroenterol. 2022 Mar 14. pii: 00000434-990000000-00275.
    PubMed     Abstract available


  20. TAKAKURA W, Pimentel M, Rao S, Villanueva-Millan MJ, et al
    A Single Fasting Exhaled Methane Level Correlates With Fecal Methanogen Load, Clinical Symptoms and Accurately Detects Intestinal Methanogen Overgrowth.
    Am J Gastroenterol. 2022;117:470-477.
    PubMed     Abstract available


    February 2022
  21. WU S, Yuan C, Liu S, Zhang Q, et al
    Irritable bowel syndrome and long-term risk of cancer: a prospective cohort study among 0.5 million adults in UK Biobank.
    Am J Gastroenterol. 2022 Feb 3. pii: 00000434-990000000-00239.
    PubMed     Abstract available


    January 2022
  22. KIKUCHI S, Oe Y, Ito Y, Sozu T, et al
    Group cognitive behavioral therapy with interoceptive exposure for drug-refractory irritable bowel syndrome: a randomized controlled trial.
    Am J Gastroenterol. 2022 Jan 29. pii: 00000434-990000000-00236.
    PubMed     Abstract available


  23. SCARLATA K, Eswaran S, Baker JR, Chey WD, et al
    Utilization of Dietitians in the Management of Irritable Bowel Syndrome by Members of the American College of Gastroenterology.
    Am J Gastroenterol. 2022 Jan 11. pii: 00000434-990000000-00184.
    PubMed     Abstract available


  24. SPIEGEL BMR, Liran O, Gale R, Khalil C, et al
    QUALITATIVE VALIDATION OF A NOVEL VIRTUAL REALITY (VR) PROGRAM FOR IRRITABLE BOWEL SYNDROME: A VR1 STUDY.
    Am J Gastroenterol. 2022 Jan 7. pii: 00000434-990000000-00189.
    PubMed     Abstract available


    December 2021
  25. GUZMAN-CARCAMO A, Navarro Gerrard C, Severino Ferreras I, Lopez Gomez J, et al
    P073 Diagnostic Outcome of Patients With Non-Specific Colitis.
    Am J Gastroenterol. 2021;116.
    PubMed     Abstract available


  26. GUEORGUIEVA I, Jacobs R, Piper M
    P019 Not All Fecal Calprotectin is Specific for Inflammatory Bowel Disease.
    Am J Gastroenterol. 2021;116.
    PubMed     Abstract available


    October 2021
  27. MAZOR Y, Trieu RQ, Prott G, Jones M, et al
    Volumetric Rectal Perception Testing: Is It Clinically Relevant? Results From a Large Patient Cohort.
    Am J Gastroenterol. 2021 Oct 5. pii: 00000434-990000000-00116.
    PubMed     Abstract available


    September 2021
  28. KAMBOJ AK, Agarwal S, Chedid VG, Iyer PG, et al
    Changes in National Google Trends and Local Healthcare Utilization After High-Impact Gastroenterology Publications.
    Am J Gastroenterol. 2021 Sep 16. pii: 00000434-990000000-00105.
    PubMed     Abstract available


  29. CHANG L, Lacy BE, Moshiree B, Kassebaum A, et al
    Efficacy of Linaclotide in Reducing Abdominal Symptoms of Bloating, Discomfort, and Pain: A Phase 3B Trial Using a Novel Abdominal Scoring System.
    Am J Gastroenterol. 2021;116:1929-1937.
    PubMed     Abstract available


    July 2021
  30. NEE J, Ballou S, Kelley JM, Kaptchuk TJ, et al
    Peppermint Oil Treatment for Irritable Bowel Syndrome: A Randomized Placebo-Controlled Trial.
    Am J Gastroenterol. 2021 Jul 28. pii: 00000434-990000000-00060.
    PubMed     Abstract available


  31. KESZTHELYI D
    Irritable Bowel Syndrome and Functional Dyspepsia: Different Ends of the Same Spectrum of Intestinal Barrier Dysfunction?
    Am J Gastroenterol. 2021;116:1556.
    PubMed    


    May 2021
  32. SHAH ED, Lacy BE, Chey WD, Chang L, et al
    Tegaserod for Irritable Bowel Syndrome With Constipation in Women Younger Than 65 Years Without Cardiovascular Disease: Pooled Analyses of 4 Controlled Trials.
    Am J Gastroenterol. 2021 May 25. pii: 00000434-900000000-98765.
    PubMed     Abstract available


  33. YU V, Ballou S, Hassan R, Singh P, et al
    Abdominal Pain and Depression, Not Bowel Habits, Predict Health Care Utilization in Patients With Functional Bowel Disorders.
    Am J Gastroenterol. 2021 May 18. pii: 00000434-900000000-98775.
    PubMed     Abstract available


  34. BRENNER DM, Lacy BE
    Antispasmodics for Chronic Abdominal Pain: Analysis of North American Treatment Options.
    Am J Gastroenterol. 2021 May 17. pii: 00000434-900000000-98778.
    PubMed     Abstract available


  35. SCHMULSON M
    Probiotics: To Use or Not to Use? That Is the Question.
    Am J Gastroenterol. 2021 May 10. pii: 00000434-900000000-98783.
    PubMed     Abstract available


    April 2021
  36. GOODOORY VC, Mikocka-Walus A, Yiannakou Y, Houghton LA, et al
    Impact of Psychological Comorbidity on the Prognosis of Irritable Bowel Syndrome.
    Am J Gastroenterol. 2021 Apr 6. pii: 00000434-900000000-98826.
    PubMed     Abstract available


  37. MIDENFJORD I, Borg A, Tornblom H, Simren M, et al
    Cumulative Effect of Psychological Alterations on Gastrointestinal Symptom Severity in Irritable Bowel Syndrome.
    Am J Gastroenterol. 2021;116:769-779.
    PubMed     Abstract available


  38. SHAH ED, Chang L, Salwen-Deremer JK, Gibson PR, et al
    Contrasting Clinician and Insurer Perspectives to Managing Irritable Bowel Syndrome: Multilevel Modeling Analysis.
    Am J Gastroenterol. 2021;116:748-757.
    PubMed     Abstract available


    March 2021
  39. BUSHYHEAD DW
    Continuing Medical Education Questions: March 2021: Irritable Bowel Syndrome in.
    Am J Gastroenterol. 2021;116:456.
    PubMed     Abstract available


    February 2021
  40. PLASSE TF
    Reply to Black and Ford.
    Am J Gastroenterol. 2021;116:429.
    PubMed    


    January 2021
  41. MOOSAVI S, Pimentel M, Wong MS, Rezaie A, et al
    Irritable Bowel Syndrome in Pregnancy.
    Am J Gastroenterol. 2021 Jan 21. pii: 00000434-900000000-98935.
    PubMed     Abstract available


  42. STALLER KD
    Continuing Medical Education Questions: January 2021.
    Am J Gastroenterol. 2021;116:16.
    PubMed     Abstract available


  43. STALLER KD
    Continuing Medical Education Questions: January 2021.
    Am J Gastroenterol. 2021;116:16.
    PubMed     Abstract available


    December 2020
  44. LACY BE, Pimentel M, Brenner DM, Chey WD, et al
    ACG Clinical Guideline: Management of Irritable Bowel Syndrome.
    Am J Gastroenterol. 2020 Dec 14. doi: 10.14309/ajg.0000000000001036.
    PubMed     Abstract available


  45. CHEY WD, Lembo AJ, Yang Y, Rosenbaum DP, et al
    Efficacy of Tenapanor in Treating Patients With Irritable Bowel Syndrome With Constipation: A 26-Week, Placebo-Controlled Phase 3 Trial (T3MPO-2).
    Am J Gastroenterol. 2020;Publish Ahead of Print.
    PubMed     Abstract available


    November 2020
  46. BLACK CJ, Ford AC
    Efficacy of Ondansetron for Irritable Bowel Syndrome With Diarrhea.
    Am J Gastroenterol. 2020 Nov 10. doi: 10.14309/ajg.0000000000000932.
    PubMed    


  47. MIDENFJORD I, Borg A, Tornblom H, Simren M, et al
    Cumulative Effect of Psychological Alterations on Gastrointestinal Symptom Severity in Irritable Bowel Syndrome.
    Am J Gastroenterol. 2020 Nov 4. doi: 10.14309/ajg.0000000000001038.
    PubMed     Abstract available


  48. STALLER K, Cash BD
    Myths and Misconceptions About Constipation: A New View for the 2020s.
    Am J Gastroenterol. 2020;115:1741-1745.
    PubMed    


    October 2020
  49. BLACK CJ, Yiannakou Y, Guthrie EA, West R, et al
    A Novel Method to Classify and Subgroup Patients With IBS Based on Gastrointestinal Symptoms and Psychological Profiles.
    Am J Gastroenterol. 2020 Oct 23. doi: 10.14309/ajg.0000000000000975.
    PubMed     Abstract available


  50. MELCHIOR C, Simren M
    Positive Effect of Bimodal Release Ondansetron in Irritable Bowel Syndrome With Diarrhea: Relevance of Low-Grade Inflammation?
    Am J Gastroenterol. 2020 Oct 19. doi: 10.14309/ajg.0000000000001022.
    PubMed     Abstract available


  51. CHEY WD, Sayuk GS, Bartolini W, Reasner DS, et al
    Randomized Trial of 2 Delayed-Release Formulations of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation.
    Am J Gastroenterol. 2020 Oct 15. doi: 10.14309/ajg.0000000000000967.
    PubMed     Abstract available


  52. SHAH ED, Chang L, Salwen-Deremer JK, Gibson PR, et al
    Contrasting Clinician and Insurer Perspectives to Managing Irritable Bowel Syndrome: Multilevel Modeling Analysis.
    Am J Gastroenterol. 2020 Oct 8. doi: 10.14309/ajg.0000000000000989.
    PubMed     Abstract available


    September 2020
  53. BARBERIO B, Houghton LA, Yiannakou Y, Savarino EV, et al
    Symptom Stability in Rome IV vs Rome III Irritable Bowel Syndrome.
    Am J Gastroenterol. 2020 Sep 28. doi: 10.14309/ajg.0000000000000946.
    PubMed     Abstract available


  54. MANSUETO P, Soresi M, Candore G, Garlisi C, et al
    Autoimmunity Features in Patients With Non-Celiac Wheat Sensitivity.
    Am J Gastroenterol. 2020 Sep 25. doi: 10.14309/ajg.0000000000000919.
    PubMed     Abstract available


    August 2020
  55. RUFFLE JK, Tinkler L, Emmett C, Ford AC, et al
    Constipation Predominant Irritable Bowel Syndrome and Functional Constipation Are Not Discrete Disorders: A Machine Learning Approach.
    Am J Gastroenterol. 2020 Aug 31. doi: 10.14309/ajg.0000000000000816.
    PubMed     Abstract available


    July 2020
  56. GUILARTE M, Vicario M, Martinez C, de Torres I, et al
    Peripheral Corticotropin-Releasing Factor Triggers Jejunal Mast Cell Activation and Abdominal Pain in Patients With Diarrhea-Predominant Irritable Bowel Syndrome.
    Am J Gastroenterol. 2020 Jul 27. doi: 10.14309/ajg.0000000000000789.
    PubMed     Abstract available


    June 2020
  57. PLASSE TF, Barton G, Davidson E, Abramson D, et al
    Bimodal Release Ondansetron Improves Stool Consistency and Symptomatology in Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized, Double-Blind, Trial.
    Am J Gastroenterol. 2020 Jun 24. doi: 10.14309/ajg.0000000000000727.
    PubMed     Abstract available


  58. CAMILLERI M, Vijayvargiya P
    The Role of Bile Acids in Chronic Diarrhea.
    Am J Gastroenterol. 2020 Jun 11. doi: 10.14309/ajg.0000000000000696.
    PubMed     Abstract available


  59. REZAIE A
    Shedding Light on Elevated Baseline Hydrogen and Flat-Line Patterns During Breath Testing.
    Am J Gastroenterol. 2020;115:956-957.
    PubMed    


    May 2020
  60. WILSON B, Rossi M, Kanno T, Parkes GC, et al
    beta-Galactooligosaccharide in Conjunction With Low FODMAP Diet Improves Irritable Bowel Syndrome Symptoms but Reduces Fecal Bifidobacteria.
    Am J Gastroenterol. 2020 May 20. doi: 10.14309/ajg.0000000000000641.
    PubMed     Abstract available


    April 2020
  61. OH SJ, Fuller G, Patel D, Khalil C, et al
    Chronic Constipation in the United States: Results From a Population-Based Survey Assessing Healthcare Seeking and Use of Pharmacotherapy.
    Am J Gastroenterol. 2020 Apr 23. doi: 10.14309/ajg.0000000000000614.
    PubMed     Abstract available


    March 2020
  62. BLACK CJ, Ford AC
    Use of Lactulose Breath Tests to Predict Response to Rifaximin in Irritable Bowel Syndrome With Diarrhea: The Positives and Negatives.
    Am J Gastroenterol. 2020 Mar 2. doi: 10.14309/ajg.0000000000000569.
    PubMed    


  63. BRENNER DM, Sayuk GS, Gutman CR, Jo E, et al
    Response to Black et al.
    Am J Gastroenterol. 2020;115:484-485.
    PubMed    


    February 2020
  64. STALLER K, Olen O, Soderling J, Roelstraete B, et al
    Mortality Risk in Irritable Bowel Syndrome: Results From a Nationwide Prospective Cohort Study.
    Am J Gastroenterol. 2020 Feb 28. doi: 10.14309/ajg.0000000000000573.
    PubMed     Abstract available


  65. DEUTSCH JK, Levitt J, Hass DJ
    Complementary and Alternative Medicine for Functional Gastrointestinal Disorders.
    Am J Gastroenterol. 2020 Feb 20. doi: 10.14309/ajg.0000000000000539.
    PubMed     Abstract available


  66. SHAH ED, Suresh S, Jou J, Chey WD, et al
    Evaluating When and Why Patients Discontinue Chronic Therapy for Irritable Bowel Syndrome With Constipation and Chronic Idiopathic Constipation.
    Am J Gastroenterol. 2020 Feb 4. doi: 10.14309/ajg.0000000000000530.
    PubMed     Abstract available


    January 2020
  67. CHEY WD, Lembo AJ, Rosenbaum DP
    Efficacy of Tenapanor in Treating Patients With Irritable Bowel Syndrome With Constipation: A 12-Week, Placebo-Controlled Phase 3 Trial (T3MPO-1).
    Am J Gastroenterol. 2020 Jan 13. doi: 10.14309/ajg.0000000000000516.
    PubMed     Abstract available


  68. BUTT I, Kasmin F, Ekekezie C, Perler BK, et al
    Understanding the Scope of Do-It-Yourself Fecal Microbiota Transplant.
    Am J Gastroenterol. 2020 Jan 10. doi: 10.14309/ajg.0000000000000499.
    PubMed     Abstract available


  69. BLACK CJ, Houghton LA, Ford AC
    Efficacy of Eluxadoline in Irritable Bowel Syndrome With Diarrhea.
    Am J Gastroenterol. 2020 Jan 10. doi: 10.14309/ajg.0000000000000518.
    PubMed    


  70. SHAH A, Talley NJ, Jones M, Kendall BJ, et al
    Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies.
    Am J Gastroenterol. 2020 Jan 6. doi: 10.14309/ajg.0000000000000504.
    PubMed     Abstract available


  71. SHAH ED, Almario CV, Spiegel BM, Chey WD, et al
    Presentation and Characteristics of Abdominal Pain Vary by Irritable Bowel Syndrome Subtype: Results of a Nationwide Population-Based Study.
    Am J Gastroenterol. 2020 Jan 6. doi: 10.14309/ajg.0000000000000502.
    PubMed     Abstract available


  72. TALLEY NJ
    What Causes Functional Gastrointestinal Disorders? A Proposed Disease Model.
    Am J Gastroenterol. 2020;115:41-48.
    PubMed     Abstract available


    November 2019
  73. REZAIE A, Heimanson Z, McCallum R, Pimentel M, et al
    Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea.
    Am J Gastroenterol. 2019 Nov 1. doi: 10.14309/ajg.0000000000000444.
    PubMed     Abstract available


    October 2019
  74. SCALLAN WALTER EJ, Crim SM, Bruce BB, Griffin PM, et al
    Postinfectious Irritable Bowel Syndrome After Campylobacter Infection.
    Am J Gastroenterol. 2019;114:1649-1656.
    PubMed     Abstract available


    September 2019
  75. DYDYK AM, Gupta N, Rej A, Trott N, et al
    A Gluten-Free Diet: The Express Route to Fructan Reduction.
    Am J Gastroenterol. 2019;114:1553.
    PubMed     Abstract available


    July 2019
  76. CASH BD, Lacy BE, Schoenfeld PS, Dove LS, et al
    Response to Lai.
    Am J Gastroenterol. 2019;114:1177-1178.
    PubMed     Abstract available


  77. LAI SW
    Safety of Eluxadoline Use.
    Am J Gastroenterol. 2019;114:1176-1177.
    PubMed    


    February 2019
  78. SCARLATA K
    Low FODMAP Diet: What Your Patients Need to Know.
    Am J Gastroenterol. 2019;114:189-191.
    PubMed    


    January 2019
  79. SCHOENFELD P, Shah ED
    Response to Sierra and Gomez.
    Am J Gastroenterol. 2019;114:169-170.
    PubMed     Abstract available


  80. SIERRA F, Gomez DG
    Efficacy and Tolerability of Guanylate Cyclase-C Agonist: Encouraging Results With Insignificant Clinical Importance.
    Am J Gastroenterol. 2019;114:169.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: